Seer (SEER) Assets Average (2021 - 2026)
Seer (SEER) recorded quarterly Assets Average of $284.1 million in Q1 2026, down 6.03% quarter-over-quarter from $302.3 million in Q4 2025, and down 20.4% on a YoY basis from $356.9 million in Q1 2025.
Seer (SEER) Assets Average (2021 - 2026) Analysis & Trends
Seer's Assets Average history runs 6 years deep, the most recent figure standing at $284.1 million for Q1 2026.
- In Q1 2026, Assets Average fell 20.4% year-over-year to $284.1 million; the TTM figure through Mar 2026 stood at $284.1 million (down 20.4% YoY), while the FY2025 annual figure was $331.3 million, down 17.46% from the prior year.
- Assets Average was $284.1 million for Q1 2026 at Seer, down from $302.3 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $533.1 million in Q1 2022 to a low of $284.1 million in Q1 2026.
- Historically, Assets Average has averaged $418.0 million across 5 years, with a median of $429.1 million in 2024.
- The sharpest annual moves came in 2022 and 2026: Assets Average climbed 7.92% in 2022, then declined 20.4% in 2026.
- A 5-year view of Assets Average shows it stood at $494.1 million in 2022, then decreased by 10.83% to $440.6 million in 2023, then slipped by 14.88% to $375.0 million in 2024, then declined by 19.38% to $302.3 million in 2025, then decreased by 6.03% to $284.1 million in 2026.
- The last three Assets Average figures came in at $284.1 million (Q1 2026), $302.3 million (Q4 2025), and $315.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 40.89 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 26.03 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 660.38 Mn |
| 10 | Seer | 99.67 Mn | 99.67 Mn | 982,000.00 | 284.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 284.11 Mn |
| Dec 31, 2025 | 302.35 Mn |
| Sep 30, 2025 | 315.55 Mn |
| Jun 30, 2025 | 334.87 Mn |
| Mar 31, 2025 | 356.93 Mn |
| Dec 31, 2024 | 375.01 Mn |
| Sep 30, 2024 | 395.02 Mn |
| Jun 30, 2024 | 414.29 Mn |
| Mar 31, 2024 | 429.12 Mn |
| Dec 31, 2023 | 440.56 Mn |
| Sep 30, 2023 | 453.02 Mn |
| Jun 30, 2023 | 466.99 Mn |
| Mar 31, 2023 | 480.36 Mn |
| Dec 31, 2022 | 494.07 Mn |
| Sep 30, 2022 | 508.26 Mn |
| Jun 30, 2022 | 521.69 Mn |
| Mar 31, 2022 | 533.11 Mn |
| Dec 31, 2021 | 533.49 Mn |
| Sep 30, 2021 | 532.44 Mn |
| Jun 30, 2021 | 541.34 Mn |